Work

Anti-Tumor Phagocytic Cell Activation in Multiple Myeloma By the IAP Antagonist LCL161: Results of a Phase II Clinical Trial

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.3039.3039

Authors: P. Leif Bergsagel, Martha Q. Lacy, David Dingli, Shaji K. Kumar, Sikander Ailawadhi, Angela Dispenzieri, Francis Buadi, Morie A. Gertz, A. Keith Stewart, Craig B. Reeder, Heidi E. Kosiorek, Amylou C. Dueck, Yi Lin, Asher Alban Chanan-Khan, Marta Chesi

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2593119093

FWCI:

Cites:

Cited by:

Related to: 10